Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways

While Taxol has been reported to improve the clinical survival of breast cancer patients, subsequently developed drug-resistance of the cancer cells limits its final efficacy and applications. Previous studies suggested that Aurora A is involved in the development of the Taxol-resistance of breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhou, Wanqi, Tang, Ke, Chen, Xiaoguang, Feng, Zhiqiang, Chen, Jindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652950/
https://www.ncbi.nlm.nih.gov/pubmed/28849180
http://dx.doi.org/10.3892/or.2017.5908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652950/
https://www.ncbi.nlm.nih.gov/pubmed/28849180
http://dx.doi.org/10.3892/or.2017.5908

Ejemplares similares